Regulation of tissue factor procoagulant activity by post-translational modifications

Thrombosis Research

Volumn 122, Issue 6, 2008, Pages 831-837

  Egorina, Elena M ^a   Sovershaev, Mikhail A ^a   Østerud, Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Glycosylation; Nitrosylation; Palmitoylation; Phosphorylation; Post translational modifications; Tissue factor procoagulant activity

Indexed keywords

PROCOAGULANT; THROMBOPLASTIN;

BLOOD CLOTTING; GLYCOSYLATION; NITROSYLATION; NONHUMAN; PALMITOYLATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PALMITIC ACID; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; THROMBOPLASTIN;

EID: 52049119056     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.11.004     Document Type: Review

References (74)

1. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Diseases 36 (2006) 104-107
2. Croce K., and Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 14 (2007) 55-61
3. Ruf W., and Mueller B.M. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 3 (1996) 379-384
4. Aebersold R., and Goodlett D.R. Mass spectrometry in proteomics. Chem Rev 101 (2001) 269-295
5. Papavassiliou A.G. Clinical practice in the new era. A fusion of molecular biology and classical medicine is transforming the way we look at and treat diseases. EMBO Rep 2 (2001) 80-82
6. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138-150
7. Fu M., Wang C., Zhang X., and Pestell R.G. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 68 (2004) 1199-1208
8. Foster M.W., McMahon T.J., and Stamler J.S. S-nitrosylation in health and disease. Trends Mol Med 9 (2003) 160-168
9. Virag L., and Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54 (2002) 375-429
10. Camerer E., Kolsto A.B., and Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 81 (1996) 1-41
11. Chen V.M., and Hogg P.J. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 4 (2006) 2533-2541
12. Campbell C.T., and Yarema K.J. Large-scale approaches for glycobiology. Genome Biol 6 (2005) 236
13. Paborsky L.R., Tate K.M., Harris R.J., Yansura D.G., Band L., McCray G., et al. Purification of recombinant human tissue factor. Biochemistry 28 (1989) 8072-8077
14. Harlos K., Martin D.M., O'Brien D.P., Jones E.Y., Stuart D.I., Polikarpov I., et al. Crystal structure of the extracellular region of human tissue factor. Nature 370 (1994) 662-666
15. Paborsky L.R., and Harris R.J. Post-translational modifications of recombinant human tissue factor. Thromb Res 60 (1990) 367-376
16. van den Besselaar A.M., and Bertina R.M. Interaction of thromboplastin apoprotein of different tissues with concanavalin A-evidence for heterogeneous glycosylation of the human apoprotein. Thromb Haemost 52 (1984) 192-195
17. Rothman J.E., and Lodish H.F. Synchronised transmembrane insertion and glycosylation of a nascent membrane protein. Nature 269 (1977) 775-780
18. Wolberg A.S., Monroe D.M., Roberts H.R., and Hoffman M.R. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis 10 (1999) 201-210
19. Nemerson Y., and Bach R. Tissue factor revisited. Prog Hemostasis Thromb 6 (1982) 237-261
20. Broze G.J. Binding of human factor VII and VIIa to monocytes. J Clin Invest 70 (1982) 526-535
21. Pitlick F.A. Concanavalin A inhibits tissue factor coagulant activity. J Clin Invest 55 (1975) 175-179
22. Shands J.W. Macrophage factor X activator formation: metabolic requirements for synthesis of components. Blood 65 (1985) 169-175
23. Bona R., Lee E., and Rickles F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 48 (1987) 487-500
24. Greengard P. Phosphorylated proteins as physiological effectors. Science 199 (1978) 146-152
25. Biondi R.M., and Nebreda A.R. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J 372 (2003) 1-13
26. Cohen P. Protein kinases-the major drug targets of the twenty-first century?. Nat Rev Drug Discov 1 (2002) 309-315
27. Mody R.S., and Carson S.D. Tissue factor cytoplasmic domain peptide is multiply phosphorylated in vitro. Biochemistry 36 (1997) 7869-7875
28. Zioncheck T.F., Roy S., and Vehar G.A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem 267 (1992) 3561-3564
29. Moreno S., and Nurse P. Substrates for p34cdc2: in vivo veritas?. Cell 61 (1990) 549-551
30. Crossman D.C., Carr D.P., Tuddenham E.G., Pearson J.D., and McVey J.H. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 265 (1990) 9782-9787
31. Scarpati E.M., and Sadler J.E. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 264 (1989) 20705-20713
32. Car B.D., Slauson D.O., Dore M., and Suyemoto M.M. Endotoxin-mediated bovine alveolar macrophage procoagulant induction is dependent on protein kinase C activation. Inflammation 14 (1990) 681-689
33. Nishizuka Y. Studies and perspectives of protein kinase C. Science 233 (1986) 305-312
34. Bach R., and Rifkin D.B. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A 87 (1990) 6995-6999
35. Hannun Y.A., and Bell R.M. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235 (1987) 670-674
36. Conkling P.R., Greenberg C.S., and Weinberg J.B. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 72 (1988) 128-133
37. Mandal S.K., Pendurthi U.R., and Rao L.V. Tissue factor trafficking in fibroblasts: involvement of protease activated receptor-mediated cell signaling. Blood 110 (2007) 161-170
38. Ott I., Fischer E.G., Miyagi Y., Mueller B.M., and Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 140 (1998) 1241-1253
39. Bromberg M.E., Sundaram R., Homer R.J., Garen A., and Konigsberg W.H. Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 82 (1999) 88-92
40. Ahamed J., and Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 279 (2004) 23038-23044
41. Belting M., Dorrell M.I., Sandgren S., Aguilar E., Ahamed J., Dorfleutner A., et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10 (2004) 502-509
42. Stone M.J., Ruf W., Miles D.J., Edgington T.S., and Wright P.E. Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J 310 Pt 2 (1995) 605-614
43. Bach R., Konigsberg W.H., and Nemerson Y. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry 27 (1988) 4227-4231
44. Dorfleutner A., and Ruf W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood 102 (2003) 3998-4005
45. Oka N., Yamamoto M., Schwencke C., Kawabe J., Ebina T., Ohno S., et al. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 272 (1997) 33416-33421
46. Couet J., Sargiacomo M., and Lisanti M.P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272 (1997) 30429-30438
47. Dietzen D.J., Page K.L., and Tetzloff T.A. Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood 103 (2004) 3038-3044
48. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (2007) 315-424
49. O'Brien D.P. The molecular biology and biochemistry of tissue factor. Bailliere's Clin Haematol 2 (1989) 801-820
50. Kirchhofer D., Eigenbrot C., Lipari M.T., Moran P., Peek M., and Kelley R.F. The tissue factor region that interacts with factor Xa in the activation of factor VII. Biochemistry 40 (2001) 675-682
51. Rehemtulla A., Ruf W., Miles D.J., and Edgington T.S. The third Trp-Lys-Ser (WKS) tripeptide motif in tissue factor is associated with a function site. Biochem J 282 Pt 3 (1992) 737-740
52. Rehemtulla A., Ruf W., and Edgington T.S. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem 266 (1991) 10294-10299
53. Ahamed J., Versteeg H.H., Kerver M., Chen V.M., Mueller B.M., Hogg P.J., et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A 103 (2006) 13932-13937
54. Le D.T., Rapaport S.I., and Rao L.V. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem 267 (1992) 15447-15454
55. Le D.T., Rapaport S.I., and Rao L.V. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide. Thromb Haemost 72 (1994) 848-855
56. Bach R.R. Tissue factor encryption. Arterioscler Thromb Vasc Biol 26 (2006) 456-461
57. Bach R.R., and Moldow C.F. Mechanism of tissue factor activation on HL-60 cells. Blood 89 (1997) 3270-3276
58. Maynard J.R., Heckman C.A., Pitlick F.A., and Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest 55 (1975) 814-824
59. Maynard J.R., Dreyer B.E., Stemerman M.B., and Pitlick F.A. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 50 (1977) 387-396
60. Carson S.D., and Archer P.G. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader. Thromb Res 41 (1986) 185-195
61. Greeno E.W., Bach R.R., and Moldow C.F. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 75 (1996) 281-289
62. Carson S.D. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagul Fibrinolysis 7 (1996) 303-313
63. Ruf W., Rehemtulla A., Morrissey J.H., and Edgington T.S. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 266 (1991) 2158-2166
64. Schmidt B., Ho L., and Hogg P.J. Allosteric disulfide bonds. Biochemistry 45 (2006) 7429-7433
65. Hogg P.J. Disulfide bonds as switches for protein function. Trends Biochem Sci 28 (2003) 210-214
66. Ellgaard L., and Ruddock L.W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep 6 (2005) 28-32
67. Lay A.J., Jiang X.M., Daly E., Sun L., and Hogg P.J. Plasmin reduction by phosphoglycerate kinase is a thiol-independent process. J Biol Chem 277 (2002) 9062-9068
68. Wang X., Terzyan S., Tang J., Loy J.A., Lin X., and Zhang X.C. Human plasminogen catalytic domain undergoes an unusual conformational change upon activation. J Mol Biol 295 (2000) 903-914
69. Pendurthi U.R., Ghosh S., Mandal S.K., and Rao L.V. Tissue factor activation: is disulfide bond switching a regulatory mechanism?. Blood 110 (2007) 39000-39008
70. Versteeg H.H., and Ruf W. Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity. J Biol Chem 282 (2007) 25416-25424
71. Zwaal R.F., and Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89 (1997) 1121-1132
72. Kunzelmann-Marche C., Satta N., Toti F., Zhang Y., Nawroth P.P., Morrissey J.H., et al. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemost 83 (2000) 282-289
73. Hoffman M., and Monroe D.M. A cell-based model of hemostasis. Thromb Haemost 85 (2001) 958-965
74. Hathcock J.J., Rusinova E., Gentry R.D., Andree H., and Nemerson Y. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions. Biochemistry 44 (2005) 8187-8197